Medifast (MED) Insider Trading & Ownership $18.58 +0.20 (+1.09%) (As of 11/1/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Medifast (NYSE:MED) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.50%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$10,287.85Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$159,850.32 MED Insider Buying and Selling by Quarter Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Medifast Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/8/2024Scott SchlackmanDirectorSell4,053$39.44$159,850.32 11/7/2023Andrea B ThomasDirectorBuy50$68.89$3,444.50 11/3/2023Jeffrey J BrownDirectorBuy97$70.55$6,843.35 (Data available from 1/1/2013 forward) MED Insider Trading Activity - Frequently Asked Questions Who is on Medifast's Insider Roster? The list of insiders at Medifast includes Andrea B Thomas, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, and Scott Schlackman. Learn more on insiders at MED. What percentage of Medifast stock is owned by insiders? 2.50% of Medifast stock is owned by insiders. Learn more on MED's insider holdings. Which Medifast insiders have been buying company stock? The following insiders have purchased MED shares in the last 24 months: Andrea B Thomas ($3,444.50), and Jeffrey J Brown ($276,460.26). How much insider buying is happening at Medifast? Insiders have purchased a total of 2,804 MED shares in the last 24 months for a total of $279,904.76 bought. Which Medifast insiders have been selling company stock? The following insiders have sold MED shares in the last 24 months: Constance J Hallquist ($414,632.31), Jeffrey J Brown ($1,403,260.40), and Scott Schlackman ($398,946.32). How much insider selling is happening at Medifast? Insiders have sold a total of 27,020 Medifast shares in the last 24 months for a total of $2,216,839.03 sold. Medifast Key ExecutivesMr. Daniel R. Chard (Age 59)Executive Chairman & CEO Compensation: $1.94MMr. James P. Maloney CPA (Age 56)Chief Financial Officer Compensation: $823.91kMr. Anthony E. Tyree (Age 59)Chief Business Operations Officer Compensation: $655.86kMr. Jason L. Groves Esq. (Age 53)Executive VP, General Counsel & Corporate Secretary Compensation: $669.51kMr. Nicholas M. Johnson (Age 44)Chief Field Operations Officer Compensation: $696.4kMr. Jonathan Barrett MacKenzie (Age 52)VP of Finance & Chief Accounting Officer Mr. Steven ZenkerVice President of Investor RelationsMs. Claudia C. Greninger (Age 51)Chief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies USNA Insider Buying HLF Insider Buying NUS Insider Buying NATR Insider Buying VERU Insider Buying EL Insider Buying IPAR Insider Buying PBH Insider Buying FARM Insider Buying JVA Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (NYSE:MED) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Medifast, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.